ASMB - Assembly Biosciences

-

$undefined

N/A

(N/A)

Assembly Biosciences NasdaqGS:ASMB Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide. Its pipeline includes long-acting helicase-primase inhibitors candidates, including ABI-5336 and ABI-1179, which are in Phase 1a/1b clinical studies for recurrent genital herpes; ABI-4334, a capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus that is in Phase 1b clinical study; and ABI-6250, an orally bioavailable hepatitis delta virus entry inhibitor that is in Phase 1a clinical study. The company also develops ABI-7423, an oral broad-spectrum non-nucleoside polymerase inhibitor that targets transplant-related herpesviruses. It has an option, license, and collaboration agreement with Gilead Sciences, Inc. for the research and development of virology therapies. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was incorporated in 2005 and is headquartered in South San Francisco, California.

Location: Two Tower Place, South San Francisco, CA, 94080, United States | Website: https://www.assemblybio.com | Industry: Biotechnology | Sector: Healthcare


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

20.45M

Cash

91.03M

Avg Qtr Burn

-14.05M

Short % of Float

0.57%

Insider Ownership

10.32%

Institutional Own.

41.72%

Qtr Updated

03/31/25


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
ABI-5366 Details
Genital herpes (HSV), Sexually transmitted infections

Phase 1b

Data readout

ABI-1179 Details
Genital herpes (HSV), Sexually transmitted infections

Phase 1b

Data readout

ABI-4334 Details
Liver infection, Liver disease, Hepatitis B

Phase 1b

Data readout

ABI-6250 Details
Liver infection, Liver disease, Hepatitis Delta Virus, Hepatitis D

Phase 1a

Data readout

ABI-H3733 Details
Liver disease, Hepatitis B, Liver infection

Failed

Discontinued

Vebicorvir (VBR, ABI-H0731) Details
Liver infection, Chronic liver disease, Hepatitis B

Failed

Discontinued

ABI-H2158 Details
Liver infection, Liver disease, Hepatitis B

Failed

Discontinued